Richard Bernstein Advisors LLC Edwards Lifesciences Corp Transaction History

Richard Bernstein Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$81.41 - $94.33 $473,887 - $549,094	-5,821 Reduced 12.11%	42,256 $3.99 Million
Q2 2022 Aug 02, 2022	BUY	$86.5 - $128.27 $308,026 - $456,769	3,561 Added 8.0%	48,077 $4.57 Million
Q3 2021 Nov 09, 2021	BUY	$102.91 - $122.75 $278,680 - $332,407	2,708 Added 6.48%	44,516 $5.04 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.3 Million - $1.74 Million	22,605 Added 117.72%	41,808 $2.89 Million
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $919,631 - $1.23 Million	19,203 New	19,203 $3.67 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Richard Bernstein Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Richard Bernstein Advisors LLC with notifications on news.